College of Medicine and Public Health

Activities

Activities per year 1974 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2023

• 262 Invited talk
• 165 Other
• 150 Oral presentation
• 25 Membership of committee
• 93 More
  • 20 Participating in a conference, workshop, ...
  • 17 Organising a conference, workshop, ...
  • 14 Editorial work
  • 12 Publication Peer-review
  • 12 Membership of network
  • 6 Visiting an external academic institution
  • 5 Consultancy
  • 4 Membership of board
  • 2 Examination
  • 1 Membership of council

Activities per year

Search results

• Australian Corneal Graft Registry report 2015

  Miriam Keane (Speaker)

  Mar 2015

  Activity: Talk or presentation types › Oral presentation

• Paramedics Australasia (External organisation)

  Brad Mitchell (Member)

  Nov 2015 → …

  Activity: Membership types › Membership of board

• Vorapaxar in the secondary prevention of atherothrombosis. Tantry US, Liu F, Chen G, Gurbel PA. Expert Rev Cardiovasc Ther. 2015 Dec;13(12):1293-305. doi: 10.1586/14779072.2015.1109447. Epub 2015 Nov 12. PMID: 26559689 Review.

  Erin Morton (Other)

  2015

  Activity: Other activity types › Other

• Should the Dose of Antiplatelet Drugs Be Adjusted for Body Weight? The Example of Vorapaxar. Serebruany VL, Fortmann SD, Kim MH. Cardiology. 2016;133(2):69-72. doi: 10.1159/000440798. Epub 2015 Oct 22. PMID: 26488178 Clinical Trial.

  Erin Morton (Other)

  2015

  Activity: Other activity types › Other

• STABILITY and SOLID-TIMI 52: Lipoprotein associated phospholipase A2 (Lp-PLA2) as a biomarker or risk factor for cardiovascular diseases. Hassan M. Glob Cardiol Sci Pract. 2015 Jan 26;2015:6. doi: 10.5339/gcsp.2015.6. eCollection 2015. PMID: 25830150.

  Erin Morton (Other)

  2015

  Activity: Other activity types › Other

• The FDA review on data quality and conduct in vorapaxar trials: Much better than in PLATO, but still not perfect. Serebruany VL, Choi SY, Kim MH. Int J Cardiol. 2016 Feb 15;205:13-16. doi: 10.1016/j.ijcard.2015.12.001. Epub 2015 Dec 3. PMID: 26709134

  Erin Morton (Other)

  2015

  Activity: Other activity types › Other

• Together for the Mental health of Older People (TMOP): a case study of facilitated reflection to problem solve networked older people's mental health services in rural South Australia

  Jeff Fuller (Speaker), Suzanne Dawson (Speaker), Eimear Muir-Cochrane (Speaker), Candice Oster (Speaker), Julie Henderson (Speaker), Deb O'Kane (Speaker), Adam Gerace (Speaker), Sharon Lawn (Speaker) & Richard Reed (Speaker)

  19 Aug 2015 → 21 Aug 2015

  Activity: Talk or presentation types › Oral presentation

• What is important to research: the cancer consumers' voice

  Sharon Lawn (Speaker) & Bogda Koczwara (Speaker)

  1 Feb 2015

  Activity: Talk or presentation types › Oral presentation

• HMDP Ministry of Health, Singapore Hand Society

  Greg Bain (Speaker)

  22 Jan 2015 → 28 Jan 2015

  Activity: Talk or presentation types › Invited talk

• Singapore Health Department

  Greg Bain (Visiting researcher)

  2015

  Activity: Visiting an external institution types › Visiting an external academic institution

• Changes in domestic and global taxation policies as a means to improve global health financing

  Fran Baum (Speaker)

  2015

  Activity: Talk or presentation types › Invited talk

• Community point-of-care testing networks for chronic, acute and infectious diseases

  Mark Shephard (Invited speaker)

  17 Aug 2015 → 21 Aug 2015

  Activity: Talk or presentation types › Invited talk

• Developing chronic disease management capacity in community health centres in Hunan Province, China

  Feng Hui (Speaker), Jeff Fuller (Speaker), Xu Shuang (Speaker), Li Huayan (Speaker), Sun Mei (Speaker), Sharon Parker (Speaker) & Sharon Lawn (Speaker)

  19 Aug 2015 → 21 Aug 2015

  Activity: Talk or presentation types › Oral presentation

• What role for primary health care nurses in cancer survivorship

  Andrea Morello (Speaker) & Sharon Lawn (Speaker)

  14 May 2015 → 16 May 2015

  Activity: Talk or presentation types › Oral presentation

• Involvement of sphingosine kinase 2 and glia in the nociceptive response to peripheral inflammation

  Jastrow Canlas (Speaker), Dusan Matusica (Speaker), Pat Vilimas (Speaker), S Pitson (Speaker) & Rainer Haberberger (Speaker)

  3 Jun 2015

  Activity: Talk or presentation types › Oral presentation

• Moral framing and community treatment orders

  Sharon Lawn (Speaker), Toni Delany-Crowe (Speaker), Mariastella Pulvirenti (Speaker) & Julie McMillan (Speaker)

  12 Jul 2015 → 17 Jul 2015

  Activity: Talk or presentation types › Oral presentation

• Getting to the heart of it: A study protocol

  T-L Kelly (Speaker), S Sundrum (Speaker), Sharon Lawn (Speaker) & Ben Hamilton (Speaker)

  1 Jan 2015

  Activity: Talk or presentation types › Oral presentation

• How do we move the IPE research agenda beyond the limits of satisfaction?

  Sharon Lawn (Speaker)

  5 Oct 2015 → 7 Oct 2015

  Activity: Talk or presentation types › Oral presentation

• Story board and E-Collage for the Dignity in Mental Health Project, World Federation for Mental Health (WFMH).

  Sharon Lawn (Participant)

  2015

  Activity: Other activity types › Other

• Unraveling Smoking and Social Disadvantage

  Billie Bonevski (Keynote speaker)

  20 Oct 2015

  Activity: Talk or presentation types › Invited talk

• Optical imaging and other visualization of the upper airway and usage of fluid dynamics physics

  Peter Eastwood (Speaker)

  Mar 2015

  Activity: Talk or presentation types › Invited talk

• Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial). Cornel JH, Tricoci P, Lokhnygina Y, Moliterno DJ, Wallentin L, Armstrong PW, Aylward PE, Clare RM, Chen E, Leonardi S, Van de Werf F, White HD, Held C, Strony J, Mahaffey KW, Harrington RA. Am J Cardiol. 2015 May 15;115(10):1325-32. doi: 10.1016/j.amjcard.2015.02.043. Epub 2015 Feb 18. PMID: 25776457 Clinical Trial.

  Erin Morton (Other)

  2015

  Activity: Other activity types › Other

• Redesigning TRACER trial after TRITON. Serebruany VL. Int J Cardiol. 2015 Oct 15;197:44-7. doi: 10.1016/j.ijcard.2015.06.020. Epub 2015 Jun 18. PMID: 26126053

  Erin Morton (Other)

  2015

  Activity: Other activity types › Other

• Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. PMID: 26052984 Clinical Trial.

  Erin Morton (Other)

  2015

  Activity: Other activity types › Other

• Clinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosis. Diehl P, Bode C, Duerschmied D. Ther Clin Risk Manag. 2015 Aug 3;11:1133-8. doi: 10.2147/TCRM.S55469. eCollection 2015. PMID: 26346960. Review.

  Erin Morton (Other)

  2015

  Activity: Other activity types › Other

• Enhancing TRK mediated trophic signalling to augment cognitive processes

  M Camara (Speaker), Dusan Matusica (Speaker), L Qian (Speaker), Timothy Bredy (Speaker), A Nykjaer (Speaker) & Elizabeth Coulson (Speaker)

  23 Aug 2015 → 27 Aug 2015

  Activity: Talk or presentation types › Oral presentation

• Joint Congress IPITA, IXA, CTS 2015

  Claire Jessup (Participant)

  17 Nov 2015

  Activity: Participating in or organising an event types › Participating in a conference, workshop, ...

• Together for the Mental health of Older People (TMOP): a case study of network problem solving for the management of older people's mental health services in rural South Australia using facilitated reflection

  Jeff Fuller (Speaker), Suzanne Dawson (Speaker), Candice Oster (Speaker), Eimear Muir-Cochrane (Speaker), Julie Henderson (Speaker), Deb O'Kane (Speaker), Adam Gerace (Speaker), Sharon Lawn (Speaker) & Richard Reed (Speaker)

  29 Jul 2015 → 31 Jul 2015

  Activity: Talk or presentation types › Oral presentation

• Guest Professor, 2nd Course of Arthroscopy and Arthroplasty of the Wrist

  Greg Bain (Speaker)

  1 Oct 2015 → 3 Oct 2015

  Activity: Talk or presentation types › Invited talk

• Guest Professor, 53rd National Congress of the Italian Society for Hand Surgery, Rome

  Greg Bain (Speaker)

  8 Oct 2015 → 9 Oct 2015

  Activity: Talk or presentation types › Invited talk

• 75th Federation of International Pharmacists World Congress of Pharmacy and Pharmaceutical Sciences

  Ross McKinnon (Member of programme committee)

  29 Sept 2015 → 3 Oct 2015

  Activity: Participating in or organising an event types › Organising a conference, workshop, ...

• Interconnections between poverty, rising inequality, and declining community and individual health outcomes

  Fran Baum (Speaker)

  16 Sept 2015

  Activity: Talk or presentation types › Invited talk

• Is chronic condition self-management relevant for people with Parkinson’s disease and the Parkinson’s workforce?

  Sharon Lawn (Speaker)

  15 May 2015

  Activity: Talk or presentation types › Oral presentation

• 50B11 cells as a peripheral sensory neuron model for sphingolipid and neurotrophin signalling

  Kagithiri Srikantharajah (Speaker), Rainer Haberberger (Speaker) & Dusan Matusica (Speaker)

  23 Aug 2015 → 27 Aug 2015

  Activity: Talk or presentation types › Oral presentation

• How HiAP entered the policy agenda in SA

  Fran Baum (Speaker)

  12 Nov 2015 → 13 Nov 2015

  Activity: Talk or presentation types › Invited talk

• Health in All Policies: an academic-policy partnership to determine the extent to which HiAP promotes health and equity in South Australia

  Fran Baum (Speaker)

  27 Oct 2015 → 28 Oct 2015

  Activity: Talk or presentation types › Invited talk

• The move from comprehensive to selective primary health care in South Australia

  Fran Baum (Speaker)

  2 Sept 2015

  Activity: Talk or presentation types › Invited talk

• Considerations in the implementation and adoption of cell-based therapies in clinical practice

  Ross McKinnon (Speaker)

  26 Sept 2015 → 3 Oct 2015

  Activity: Talk or presentation types › Invited talk

• The WONCA Special Interest Group on Global POCT

  Mark Shephard (Invited speaker)

  15 Apr 2015

  Activity: Talk or presentation types › Invited talk

  File

• Smoke-free Prisons Panel Symposium

  Sharon Lawn (Speaker)

  22 Oct 2015

  Activity: Talk or presentation types › Oral presentation

• 50B11 cells as a peripheral sensory neuron model for sphingolipid and neurotrophin signalling

  Kagithiri Srikantharajah (Speaker), Rainer Haberberger (Speaker) & Dusan Matusica (Speaker)

  23 Sept 2015 → 25 Sept 2015

  Activity: Talk or presentation types › Oral presentation

• The upper airway in OSA

  Peter Eastwood (Invited speaker)

  Dec 2015

  Activity: Talk or presentation types › Invited talk

• Diffusion capacity – pitfalls and interpretation

  Peter Eastwood (Invited speaker)

  Dec 2015

  Activity: Talk or presentation types › Invited talk

• Adelaide University Sciences Association (AUScA) (External organisation)

  Charlotte Downes (Member)

  Mar 2014 → Feb 2017

  Activity: Membership types › Membership of network

• Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial). Valgimigli M, Tricoci P, Huang Z, Aylward PE, Armstrong PW, Van de Werf F, Leonardi S, White HD, Widimsky P, Harrington RA, Cequier A, Chen E, Lokhnygina Y, Wallentin L, Strony J, Mahaffey KW, Moliterno DJ. Am J Cardiol. 2014 Sep 1;114(5):665-73. doi: 10.1016/j.amjcard.2014.05.054. Epub 2014 Jun 18. PMID: 25129064 Clinical Trial.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial. Tricoci P, Lokhnygina Y, Huang Z, Van de Werf F, Cornel JH, Chen E, Wallentin L, Held C, Aylward PE, Moliterno DJ, Jennings LK, White HD, Armstrong PW, Harrington RA, Strony J, Mahaffey KW. Am Heart J. 2014 Dec;168(6):869-77.e1. doi: 10.1016/j.ahj.2014.09.002. Epub 2014 Sep 16. PMID: 25458650 Clinical Trial.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial). Mahaffey KW, Huang Z, Wallentin L, Storey RF, Jennings LK, Tricoci P, White HD, Armstrong PW, Aylward PE, Moliterno DJ, Van de Werf F, Chen E, Leonardi S, Rorick T, Held C, Strony J, Harrington RA. Am J Cardiol. 2014 Mar 15;113(6):936-44. doi: 10.1016/j.amjcard.2013.11.052. Epub 2013 Dec 25. PMID: 24444781 Clinical Trial.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Darapladib for preventing ischemic events in stable coronary heart disease. STABILITY Investigators, White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim HS, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler ER 3rd, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse HF, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. N Engl J Med. 2014 May 1;370(18):1702-11. doi: 10.1056/NEJMoa1315878. Epub 2014 Mar 30. PMID: 24678955 Clinical Trial.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy. Storey RF, Kotha J, Smyth SS, Moliterno DJ, Rorick TL, Moccetti T, Valgimigli M, Dery JP, Cornel JH, Thomas GS, Huber K, Harrington RA, Hord E, Judge HM, Chen E, Strony J, Mahaffey KW, Tricoci P, Becker RC, Jennings LK. Thromb Haemost. 2014 May 5;111(5):883-91. doi: 10.1160/TH13-07-0624. Epub 2014 Jan 9. PMID: 24402559 Clinical Trial.

  Erin Morton (Other)

  2014

  Activity: Other activity types › Other

• Chronic disease management translation: implementation models and the Flinders Program

  Malcolm Battersby (Speaker), Melanie Harris (Speaker), Sharon Lawn (Speaker) & Andrea Morello (Speaker)

  12 Nov 2014

  Activity: Talk or presentation types › Oral presentation